Magdalena Jonikas

Partner at JEITO

Speaker

Magdalena brings 15 years of international biopharma experience across strategy, investing and operating. Her deep scientific expertise, commercial acumen and operational leadership are complemented by a proven track record in investing, company creation and board leadership.

Prior to Jeito, Magdalena was a Partner at Syncona Ltd., where she led the creation, financing, and strategic development of therapeutics companies including OMass Therapeutics, Kesmalea Therapeutics and Mosaic Therapeutics. She served as an investor director on portfolio company boards, and took on operating leadership responsibilities, including as interim CEO of Mosaic Therapeutics.

Before that, Magdalena was an Associate Partner at McKinsey & Company in Palo Alto (USA) and London (UK), where she advised global pharmaceutical and healthcare clients on strategy across the value chain, and led commercial due diligence across therapeutics, medtech, and services.

Magdalena completed a postdoctoral fellowship at Harvard Medical School and Boston Children’s Hospital (USA) after earning a Ph.D. and an M.S. in Bioengineering from Stanford University (USA), and a Bachelor of Science in Engineering (BSE) in Bioengineering from the University of Pennsylvania (USA).